Cue Biopharma Inc buy Oppenheimer Holdings Inc.
Start price
22.03.23
/
50%
€3.00
Target price
22.03.24
€9.27
Performance (%)
-42.17%
End price
23.03.24
€1.74
Summary
This prediction ended on 23.03.24 with a price of €1.74. Massive losses of -42.17% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cue Biopharma Inc | 49.194% | 49.194% | -16.163% | -82.074% |
| iShares Core DAX® | 2.287% | 9.963% | 14.444% | 52.099% |
| iShares Nasdaq 100 | 4.537% | 8.787% | 40.868% | 92.393% |
| iShares Nikkei 225® | 2.813% | 14.081% | 47.188% | 62.927% |
| iShares S&P 500 | 3.096% | 6.854% | 31.173% | 65.646% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten